Genotypes and phenotypes of neurofibromatosis type 1 patients in Japan: A Hereditary Tumor Cohort Study
2024

Genetic and Clinical Characteristics of Neurofibromatosis Type 1 in Japan

Sample size: 44 publication Evidence: moderate

Author Information

Author(s): Futagawa Mashu, Okazaki Tetsuya, Nakata Eiji, Fukano Chika, Osumi Risa, Kato Fumino, Urakawa Yusaku, Yamamoto Hideki, Ozaki Toshifumi, Hirasawa Akira

Primary Institution: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Hypothesis

This study aimed to elucidate the detailed genetic and clinical characteristics of NF1 in a hereditary tumor cohort.

Conclusion

The study found that 92.3% of suspected patients with NF1 had detectable genetic changes linked to NF1, highlighting the importance of genetic testing in managing the condition.

Supporting Evidence

  • 81.8% of patients had germline pathogenic variants.
  • 40.0% of adult patients presented with malignancies.
  • Hypertension was observed in 30.6% of adult patients.

Takeaway

Neurofibromatosis type 1 is a genetic disorder that can cause skin changes and tumors, and this study shows that many patients have genetic changes that can help doctors take better care of them.

Methodology

The study involved genetic testing and clinical data analysis of 44 patients with suspected NF1, using sequencing and copy number assays.

Limitations

The study is limited by its relatively small sample size and the cross-sectional nature of data collection.

Participant Demographics

The cohort included 44 patients, with a slight predominance of females and a wide age range at the first visit.

Digital Object Identifier (DOI)

10.1038/s41439-024-00299-4

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication